We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
TIDMGSK
RNS Number : 2974U
GlaxoSmithKline PLC
16 January 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Sir Andrew Witty === ======================== ================================================ b) Position/status Chief Executive Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP15.66 406.772 (personal contribution) --------- -------------------------------- GBP15.66 406.759 (personal contribution) --------- -------------------------------- GBP15.66 203.865 (personal contribution) --------- -------------------------------- GBP15.66 203.865 (personal contribution) --------- -------------------------------- GBP15.66 510.713 (personal contribution) --------- -------------------------------- GBP15.66 406.772 (matching shares) --------- -------------------------------- GBP15.66 406.759 (matching shares) --------- -------------------------------- GBP15.66 203.865 (matching shares) --------- -------------------------------- GBP15.66 203.865 (matching shares) --------- -------------------------------- GBP15.66 510.713 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 3,463.948 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Ms E Walmsley === ======================== ================================================ b) Position/status CEO Designate === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP15.66 89.065 (personal contribution) --------- -------------------------------- GBP15.66 89.065 (personal contribution) --------- -------------------------------- GBP15.66 71.015 (personal contribution) --------- -------------------------------- GBP15.66 71.015 (personal contribution) --------- -------------------------------- GBP15.66 175.863 (personal contribution) --------- -------------------------------- GBP15.66 175.850 (personal contribution) --------- -------------------------------- GBP15.66 89.065 (matching shares) --------- -------------------------------- GBP15.66 89.065 (matching shares) --------- -------------------------------- GBP15.66 71.015 (matching shares) --------- -------------------------------- GBP15.66 71.015 (matching shares) --------- -------------------------------- GBP15.66 175.863 (matching shares) --------- -------------------------------- GBP15.66 175.850 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,343.746 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr R G Connor === ======================== ================================================ b) Position/status President, Global Manufacturing & Supply === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP15.66 79.620 (personal contribution) --------- -------------------------------- GBP15.66 79.607 (personal contribution) --------- -------------------------------- GBP15.66 52.007 (personal contribution) --------- -------------------------------- GBP15.66 52.007 (personal contribution) --------- -------------------------------- GBP15.66 119.484 (personal contribution) --------- -------------------------------- GBP15.66 79.620 (matching shares) --------- -------------------------------- GBP15.66 79.607 (matching shares) --------- -------------------------------- GBP15.66 52.007 (matching shares) --------- -------------------------------- GBP15.66 52.007 (matching shares) --------- -------------------------------- GBP15.66 119.484 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 765.45 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr S Dingemans === ======================== ================================================ b) Position/status Chief Financial Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP15.66 192.213 (personal contribution) --------- -------------------------------- GBP15.66 76.874 (personal contribution) --------- -------------------------------- GBP15.66 99.193 (personal contribution) --------- -------------------------------- GBP15.66 99.180 (personal contribution) --------- -------------------------------- GBP15.66 232.242 (personal contribution) --------- -------------------------------- GBP15.66 232.229 (personal contribution) --------- -------------------------------- GBP15.66 192.213 (matching shares) --------- -------------------------------- GBP15.66 76.874 (matching shares) --------- -------------------------------- GBP15.66 99.193 (matching shares) --------- -------------------------------- GBP15.66 99.180 (matching shares) --------- -------------------------------- GBP15.66 232.242 (matching shares) --------- -------------------------------- GBP15.66 232.229 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,863.862 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr N Hirons === ======================== ================================================ b) Position/status SVP, Global Ethics & Compliance === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- GBP15.66 36.414 (personal contribution) --------- ------------------------------- GBP15.66 36.414 (personal contribution) --------- -------------------------------
GBP15.66 85.869 (personal contribution) --------- ------------------------------- GBP15.66 85.869 (personal contribution) --------- ------------------------------- GBP15.66 36.414 (matching shares) --------- ------------------------------- GBP15.66 36.414 (matching shares) --------- ------------------------------- GBP15.66 85.869 (matching shares) --------- ------------------------------- GBP15.66 85.869 (matching shares) --------- ------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 489.132 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr S A Hussain === ======================== ================================================ b) Position/status President, Global Pharmaceuticals === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP15.66 116.783 (personal contribution) --------- -------------------------------- GBP15.66 171.654 (personal contribution) --------- -------------------------------- GBP15.66 202.916 (personal contribution) --------- -------------------------------- GBP15.66 202.916 (personal contribution) --------- -------------------------------- GBP15.66 116.783 (matching shares) --------- -------------------------------- GBP15.66 171.654 (matching shares) --------- -------------------------------- GBP15.66 202.916 (matching shares) --------- -------------------------------- GBP15.66 202.916 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,388.538 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr D S Redfern === ======================== ================================================ b) Position/status Chief Strategy Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP15.66 72.618 (personal contribution) --------- -------------------------------- GBP15.66 72.605 (personal contribution) --------- -------------------------------- GBP15.66 58.351 (personal contribution) --------- -------------------------------- GBP15.66 58.351 (personal contribution) --------- -------------------------------- GBP15.66 109.284 (personal contribution) --------- -------------------------------- GBP15.66 109.284 (personal contribution) --------- -------------------------------- GBP15.66 72.618 (matching shares) --------- -------------------------------- GBP15.66 72.605 (matching shares) --------- -------------------------------- GBP15.66 58.351 (matching shares) --------- -------------------------------- GBP15.66 58.351 (matching shares) --------- -------------------------------- GBP15.66 109.284 (matching shares) --------- -------------------------------- GBP15.66 109.284 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 960.986 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === =========================================================================
a) Name Dr M M Slaoui === ======================== =============================================== b) Position/status Chairman, Global Vaccines === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 12 January 2017 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- $39.01 125.340 (personal contribution) --------- -------------------------------- $39.01 125.327 (personal contribution) --------- -------------------------------- $39.01 78.047 (personal contribution) --------- -------------------------------- $39.01 78.047 (personal contribution) --------- -------------------------------- $39.01 128.475 (personal contribution) --------- -------------------------------- $39.01 128.475 (personal contribution) --------- -------------------------------- $39.01 125.340 (matching shares) --------- -------------------------------- $39.01 125.327 (matching shares) --------- -------------------------------- $39.01 78.047 (matching shares) --------- -------------------------------- $39.01 78.047 (matching shares) --------- -------------------------------- $39.01 128.475 (matching shares) --------- -------------------------------- $39.01 128.475 (matching shares) --------- -------------------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 1,327.422 $39.01 === ======================== =============================================== e) Date of the transaction 2017-01-12 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Ms C Thomas === ======================== ================================================ b) Position/status SVP, Human Resources === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP15.66 90.103 (personal contribution) --------- -------------------------------- GBP15.66 78.542 (personal contribution) --------- -------------------------------- GBP15.66 78.530 (personal contribution) --------- -------------------------------- GBP15.66 159.879 (personal contribution) --------- -------------------------------- GBP15.66 159.879 (personal contribution) --------- -------------------------------- GBP15.66 90.103 (matching shares) --------- -------------------------------- GBP15.66 78.542 (matching shares) --------- -------------------------------- GBP15.66 78.530 (matching shares) --------- -------------------------------- GBP15.66 159.879 (matching shares) --------- -------------------------------- GBP15.66 159.879 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,133.866 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr P C Thomson === ======================== ================================================ b) Position/status SVP, Communications & Government Affairs === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882
=== ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- GBP15.66 54.266 (personal contribution) --------- ------------------------------- GBP15.66 53.347 (personal contribution) --------- ------------------------------- GBP15.66 97.819 (personal contribution) --------- ------------------------------- GBP15.66 54.266 (matching shares) --------- ------------------------------- GBP15.66 53.347 (matching shares) --------- ------------------------------- GBP15.66 97.819 (matching shares) --------- ------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 410.864 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr D E Troy === ======================== =============================================== b) Position/status SVP & General Counsel === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 12 January 2017 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- $39.01 50.726 (personal contribution) --------- ------------------------------- $39.01 50.726 (personal contribution) --------- ------------------------------- $39.01 40.386 (personal contribution) --------- ------------------------------- $39.01 40.386 (personal contribution) --------- ------------------------------- $39.01 90.932 (personal contribution) --------- ------------------------------- $39.01 90.932 (personal contribution) --------- ------------------------------- $39.01 50.726 (matching shares) --------- ------------------------------- $39.01 50.726 (matching shares) --------- ------------------------------- $39.01 40.386 (matching shares) --------- ------------------------------- $39.01 40.386 (matching shares) --------- ------------------------------- $39.01 90.932 (matching shares) --------- ------------------------------- $39.01 90.932 (matching shares) --------- ------------------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 728.176 $39.01 === ======================== =============================================== e) Date of the transaction 2017-01-12 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Dr P J T Vallance === ======================== ================================================ b) Position/status President, Pharmaceuticals R&D === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 12 January 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP15.66 161.014 (personal contribution) --------- -------------------------------- GBP15.66 161.001 (personal contribution) --------- -------------------------------- GBP15.66 115.614 (personal contribution) --------- -------------------------------- GBP15.66 115.614 (personal contribution) --------- -------------------------------- GBP15.66 188.068 (personal contribution) --------- -------------------------------- GBP15.66 188.068 (personal contribution) --------- -------------------------------- GBP15.66 161.014 (matching shares) --------- -------------------------------- GBP15.66 161.001 (matching shares) --------- -------------------------------- GBP15.66 115.614 (matching shares)
--------- -------------------------------- GBP15.66 115.614 (matching shares) --------- -------------------------------- GBP15.66 188.068 (matching shares) --------- -------------------------------- GBP15.66 188.068 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,858.758 GBP15.66 === ======================== ================================================ e) Date of the transaction 2017-01-12 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHVQLFFDFFLBBB
(END) Dow Jones Newswires
January 16, 2017 13:25 ET (18:25 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions